David S.P. Tan

Research interests

Publications

• ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease

  Annals of Oncology · 2024 · https://doi.org/10.1016/j.annonc.2023.11.015

• Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

  Annals of Oncology · 2023 · https://doi.org/10.1016/j.annonc.2023.07.011

• Adavosertib plus gemcitabine for platinum-resistant or platinum-refractory recurrent ovarian cancer: a double-blind, randomised, placebo-controlled, phase 2 trial

  The Lancet · 2021 · https://doi.org/10.1016/s0140-6736(20)32554-x

• First-in-Human Trial of the Oral Ataxia Telangiectasia and RAD3-Related (ATR) Inhibitor BAY 1895344 in Patients with Advanced Solid Tumors

  Cancer Discovery · 2020 · https://doi.org/10.1158/2159-8290.cd-20-0868

• ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease

  Annals of Oncology · 2019 · https://doi.org/10.1093/annonc/mdz062

• Biomarkers for Homologous Recombination Deficiency in Cancer

  JNCI Journal of the National Cancer Institute · 2018 · https://doi.org/10.1093/jnci/djy085

• Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research

  Nature reviews. Cancer · 2013 · https://doi.org/10.1038/nrc3432

• Breast cancer molecular profiling with single sample predictors: a retrospective analysis

  The Lancet Oncology · 2010 · https://doi.org/10.1016/s1470-2045(10)70008-5

• PPM1D Is a Potential Therapeutic Target in Ovarian Clear Cell Carcinomas

  Clinical Cancer Research · 2009 · https://doi.org/10.1158/1078-0432.ccr-08-2403

• Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescence in situ hybridization and microarray‐based CGH analysis

  The Journal of Pathology · 2009 · https://doi.org/10.1002/path.2574

• Tiling Path Genomic Profiling of Grade 3 Invasive Ductal Breast Cancers

  Clinical Cancer Research · 2009 · https://doi.org/10.1158/1078-0432.ccr-08-1878

• “BRCAness” Syndrome in Ovarian Cancer: A Case-Control Study Describing the Clinical Features and Outcome of Patients With Epithelial Ovarian Cancer Associated With BRCA1 and BRCA2 Mutations

  Journal of Clinical Oncology · 2008 · https://doi.org/10.1200/jco.2008.16.1703

• Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients

  Breast Cancer Research and Treatment · 2007 · https://doi.org/10.1007/s10549-007-9756-8

• Mechanisms of transcoelomic metastasis in ovarian cancer

  The Lancet Oncology · 2006 · https://doi.org/10.1016/s1470-2045(06)70939-1

Current projects

No projects listed.